Wells Fargo & Company Xenon Pharmaceuticals Inc. Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

A detailed history of Wells Fargo & Company transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 60,456 shares of XENE stock, worth $2.32 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
60,456
Previous 59,067 2.35%
Holding current value
$2.32 Million
Previous $2.3 Million 3.26%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$36.12 - $43.96 $50,170 - $61,060
1,389 Added 2.35%
60,456 $2.38 Million
Q2 2024

Aug 13, 2024
SELL
$36.25 - $43.75 $86,637 - $104,562
-2,390 Reduced 3.89%
59,067 $2.3 Million
Q1 2024

May 10, 2024
BUY
$42.66 - $50.04 $129,430 - $151,821
3,034 Added 5.19%
61,457 $2.65 Million
Q4 2023

Feb 09, 2024
SELL
$28.7 - $46.46 $34,727 - $56,216
-1,210 Reduced 2.03%
58,423 $2.69 Million
Q3 2023

Nov 13, 2023
BUY
$34.16 - $39.73 $35,526 - $41,319
1,040 Added 1.77%
59,633 $2.04 Million
Q2 2023

Aug 15, 2023
BUY
$34.84 - $43.54 $1.9 Million - $2.38 Million
54,647 Added 1384.87%
58,593 $2.26 Million
Q1 2023

May 12, 2023
BUY
$33.46 - $40.35 $94,457 - $113,908
2,823 Added 251.38%
3,946 $141,000
Q4 2022

Feb 13, 2023
BUY
$33.06 - $39.43 $20,596 - $24,564
623 Added 124.6%
1,123 $44,000
Q3 2022

Nov 14, 2022
BUY
$30.79 - $39.82 $15,395 - $19,910
500 New
500 $18,000

About Xenon Pharmaceuticals Inc.

XENE Quotes by TradingView
  • Ticker XENE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,263,500
  • Market Cap $2.39B
  • Description
  • Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...
More about XENE
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email